Literature DB >> 3145196

The human Lyt-3 molecule requires CD8 for cell surface expression.

J P DiSanto1, R W Knowles, N Flomenberg.   

Abstract

We have previously identified a monoclonal antibody, T8/2T8-5H7, which clustered serologically with CD8 monoclonal antibodies, but lacked reactivity with L cell transfectants expressing the human CD8 molecule (Lyt-2 homologue). Based on these observations, we postulated that T8/2T8-5H7 might recognize the human Lyt-3 gene product. To test this hypothesis, we have isolated a full-length cDNA encoding the human Lyt-3 molecule and have characterized its product in additional transfection experiments. The results of these studies indicate that the human Lyt-3 cDNA encodes a product recognized by the antibody T8/2T8-5H7. Interestingly, the human Lyt-3 molecule cannot be expressed alone, but requires the human Lyt-2 homologue for efficient cell surface expression. A heterodimer composed of the human Lyt-2 and Lyt-3 molecules may have importance in T cell-target cell interactions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145196      PMCID: PMC454846          DOI: 10.1002/j.1460-2075.1988.tb03221.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  30 in total

1.  Phosphorylation of CD4 and CD8 molecules following T cell triggering.

Authors:  M L Blue; D A Hafler; K A Craig; H Levine; S F Schlossman
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

2.  The isolation and sequence of the gene encoding T8: a molecule defining functional classes of T lymphocytes.

Authors:  D R Littman; Y Thomas; P J Maddon; L Chess; R Axel
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

3.  The mouse Lyt-2/3 antigen complex--I. Mode of association of the subunits with the membrane.

Authors:  B Luescher; H Y Naim; H R MacDonald; C Bron
Journal:  Mol Immunol       Date:  1984-04       Impact factor: 4.407

4.  Comparison of thymic and peripheral T cell Ly-2/3 antigens.

Authors:  I D Walker; B J Murray; P M Hogarth; A Kelso; I F McKenzie
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

5.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

Review 6.  Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes (CTL): possible implications for the affinity of CTL antigen receptors.

Authors:  H R MacDonald; A L Glasebrook; C Bron; A Kelso; J C Cerottini
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

Review 7.  T cell subsets and the recognition of MHC class.

Authors:  S L Swain
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

8.  The T8 antigen is a multimeric complex of two distinct subunits on human thymocytes but consists of homomultimeric forms on peripheral blood T lymphocytes.

Authors:  P M Snow; C Terhorst
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

9.  Isolation of the gene encoding the human T-lymphocyte differentiation antigen Leu-2 (T8) by gene transfer and cDNA subtraction.

Authors:  P Kavathas; V P Sukhatme; L A Herzenberg; J R Parnes
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  13 in total

1.  GRASP65 and GRASP55 sequentially promote the transport of C-terminal valine-bearing cargos to and through the Golgi complex.

Authors:  Giovanni D'Angelo; Libera Prencipe; Luisa Iodice; Galina Beznoussenko; Marco Savarese; Pierfrancesco Marra; Giuseppe Di Tullio; Gianluca Martire; Maria Antonietta De Matteis; Stefano Bonatti
Journal:  J Biol Chem       Date:  2009-10-19       Impact factor: 5.157

2.  Short related sequences in the cytoplasmic domains of CD4 and CD8 mediate binding to the amino-terminal domain of the p56lck tyrosine protein kinase.

Authors:  A S Shaw; J Chalupny; J A Whitney; C Hammond; K E Amrein; P Kavathas; B M Sefton; J K Rose
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

3.  Characterization of the mouse CD8 beta chain-encoding gene promoter region.

Authors:  Y Kawachi; F Otsuka; H Nakauchi
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Structure and expression of the gene encoding CD8 alpha chain (Leu-2/T8).

Authors:  K Nakayama; S Tokito; K Okumura; H Nakauchi
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Soluble CD8 in patients with rheumatic diseases.

Authors:  J A Symons; N C Wood; F S di Giovine; G W Duff
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

6.  Expression of CD8alpha identifies a distinct subset of effector memory CD4+ T lymphocytes.

Authors:  Iole Macchia; Marie-Claire Gauduin; Amitinder Kaur; R Paul Johnson
Journal:  Immunology       Date:  2006-07-12       Impact factor: 7.397

7.  Delineation of multiple subpopulations of natural killer cells in rhesus macaques.

Authors:  Ramothea L Webster; R Paul Johnson
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

8.  The murine CD94/NKG2 ligand, Qa-1b, is a high-affinity, functional ligand for the CD8αα homodimer.

Authors:  Katharine Jennifer Goodall; Angela Nguyen; Craig McKenzie; Sidonia Barbara Guiomar Eckle; Lucy Catherine Sullivan; Daniel Mark Andrews
Journal:  J Biol Chem       Date:  2020-01-28       Impact factor: 5.157

9.  Phosphorylation and down-regulation of CD4 and CD8 in human CTLs and mouse L cells.

Authors:  J P DiSanto; J S Klein; N Flomenberg
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

10.  Cloning and chromosome mapping of human retinoid X receptor beta: selective amino acid sequence conservation of a nuclear hormone receptor in mammals.

Authors:  K Fleischhauer; O W McBride; J P DiSanto; K Ozato; S Y Yang
Journal:  Hum Genet       Date:  1993-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.